Company news
Biomark Diagnostics, Inc. (CSE:BUX) news
Every Biomark Diagnostics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
BioMark's Metabolomics Platform Captures Global Scientific Interest Following Publications Demonstrating Superior Diagnostic Performance ...
August 25, 2026
BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day
July 31, 2026
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test
June 23, 2026
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
April 14, 2026
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers i...
January 15, 2026
BioMark: 2025 Achievements & 2026 Vision
December 31, 2025
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
December 30, 2025
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
December 23, 2025
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
December 1, 2025
BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy
November 12, 2025
BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial
October 7, 2025
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy
September 29, 2025
BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership
August 12, 2025
BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International...
August 5, 2025
BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026
July 30, 2025
BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology
May 20, 2025
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
May 12, 2025
BioMark Diagnostics Announces Uplisting to OTCQB Venture Market
May 8, 2025
BioMark Announces the Final Closing of Oversubscribed Private Placement
March 31, 2025
BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform
March 26, 2025
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025
February 28, 2025